Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia.

Dreyzin A, Shao L, Cai Y, Han KL, Prochazkova M, Gertz M, Yates B, Shi R, Martin K, Taylor N, Highfill S, O'Neill M, Andresson T, Stroncek D, Jin P, Shah NN

Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe.

Grueger J, Martin K, Sullivan SD

Correction: Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.

Ehrmann D, Krause-Steinrauf H, Uschner D, Wen H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Arends VL, Cohen RM, Garvey WT, Martens T, Willis HJ, Cherrington A, Gonzalez JS, GRADE Research Group

Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study.

Thomas RM, Sparks AD, Wilkinson K, Gergi M, Repp AB, Roetker NS, Smith NL, Muthukrishnan P, Martin K, Zakai NA

The Cost of Antivenom: A Cost Minimization Study using the North American Snakebite Registry.

Herzel B, Batavia N, Gavaza P, Phan T, Samones E, Ruha AM, Furmaga J, Hoyte C, Wolk BJ, ToxIC Snakebite Study Group

Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study.

Gergi M, Wilkinson K, Sparks A, Roetker NS, Al-Samkari H, Smith NL, Plante TB, Cushman M, Repp AB, Holmes CE, Martin K, Zakai NA

Cargo-less Nanoparticles Prevent Bone Loss in Periodontitis and Peri-implantitis.

Saleh MHA, Roh A, Martin K, Mianecki M, Tariq Sheikh A, Singh P, Akorede K, Saunders MN, Shea LD, Decker A, Decker JT

Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.

Ehrmann D, Krause-Steinrauf H, Uschner D, Wen H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Arends VL, Cohen RM, Garvey WT, Martens T, Willis HJ, Cherrington A, Gonzalez JS, GRADE Research Group

Data bias.

Martin KD

Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.

Luchsinger JA, Rosin SP, Kazemi EJ, Younes N, Suratt CE, Fattaleh BN, Florez HJ, Gonzalez JS, Hollander P, Hox SH, Kuo S, Lee MS, Martens T, Pop-Busui R, Seaquist ER, Waltje AH, Barzilay JI, GRADE Research Group

Radiographic Results of Percutaneous Reduction of Calcaneal Fractures and Posterior Arthroscopic Subtalar Arthrodesis (C-PASTA).

Anand S, Belmonte AD, Grzeskiewicz E, Groth A, Martin KD

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Gonzalez-Robles C, Athauda D, Barber TR, Barker RA, Dexter DT, Duty S, Ellis-Doyle R, Gandhi S, Handley J, Jabbari E, Martin K, McFarthing K, Mills G, Mortiboys H, Mullin S, Petty R, Sammler E, Scurfield P, Stott SRW, Tofaris GK, Wei L, Williams-Gray CH, Wong A, Zeissler ML, Wyse RK, Carroll CB, Foltynie T, Bandmann O, Schapira AHV, EJS ACT‐PD Consortium

Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer's disease.

Bu XL, Zhu W, Wang QH, Liu ZT, Bao YY, Bai YD, Li JH, Liu ZH, Zhao JL, Xiang Y, Jin WS, Wang J, Lei X, Wang YJ, Alzheimer’s Disease Neuroimaging Initiative

Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium.

Trongtorsak A, De La Rosa Martinez J, Crawford TC, Bogun FM, Gu X, Puroll E, Ellenbogen KA, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, DeLurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Torosoff M, Judson MA, Martin K, Madias C, Hermel M, Nour K, Torbey E, Sauer WH, Kron J, Cardiac Sarcoidosis Consortium

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.

Desai AS, Karns AD, Badariene J, Aswad A, Neutel JM, Kazi F, Park W, Stiglitz D, Makarova N, Havasi A, Zappe DH, Saxena M, KARDIA-2 Study Group